Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

281
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
281
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

578
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
578
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

250
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
250
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

548
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
548
One-Compartment Open Model: Urinary Excretion Data and Determination of k01:11

One-Compartment Open Model: Urinary Excretion Data and Determination of k

639
The one-compartment open model leverages urinary excretion data to estimate renal clearance, which gauges the kidney's capacity to expel a drug. This method offers several benefits, including directly measuring drug elimination and assessing the kidney's contribution to overall drug clearance. However, this approach has limitations. It assumes sole renal excretion of the drug, which is not true for all drugs. Accurate urinary excretion and plasma drug concentration measurement can also...
639
How Data are Classified: Categorical Data01:11

How Data are Classified: Categorical Data

45.2K
A variable, usually notated by capital letters such as X and Y, is a characteristic or measurement that can be determined for each member of a population. Data are the actual values of variables. They may be numbers, or they may be words. Datum is a single value.
Data are classified based on whether they are measurable or not. Categorical data cannot be measured; instead, it can be divided into categories. For example, if Y denotes a person's party affiliation, some examples of Y include...
45.2K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Data-Driven Predictions of Diastereoselectivity in Crystallization-Induced Diastereomer Transformations.

Organic letters·2026
Same author

Data Science and High-Throughput Spectroelectrochemistry-Guided Interrogation of Sulfonate Anions for OMIECs.

Journal of the American Chemical Society·2026
Same author

Assessment of Complementary Catalysts in an Uncharted Enantioselective Reaction of Sulfondiimines.

Journal of the American Chemical Society·2026
Same author

Best Practices and Considerations for Applying Multiple Linear Regression in Organic Chemistry Research.

The Journal of organic chemistry·2026
Same author

Synergizing Chemical and AI Communities for Advancing Laboratories of the Future.

ACS central science·2026
Same author

Markovnikov hydroamination of terminal alkenes by phosphine redox catalysis.

Nature·2026
Same journal

Daily briefing: 'Cyborg' cockroaches breathe underwater with printed suit.

Nature·2026
Same journal

China boosts prestigious grants for young scientists - will it ease competition?

Nature·2026
Same journal

Incoming US science academy chief vows to 'double down' on research.

Nature·2026
Same journal

Author Correction: Synthesis of enantioenriched atropisomers by biocatalytic deracemization.

Nature·2026
Same journal

Electrodeposited self-assembled molecules for perovskite photovoltaics.

Nature·2026
Same journal

Neutrino's nursery found: the 'Shadow Blaster'.

Nature·2026
関連記事をすべて見る

関連する実験動画

Updated: Feb 13, 2026

Development of Heterogeneous Enantioselective Catalysts using Chiral Metal-Organic Frameworks MOFs
08:25

Development of Heterogeneous Enantioselective Catalysts using Chiral Metal-Organic Frameworks MOFs

Published on: January 17, 2020

7.8K

散らばったデータから得られた移転可能なエナチオセレクティビティモデル.

Simone Gallarati1,2, Erin M Bucci2, Abigail G Doyle3

  • 1Department of Chemistry, University of Utah, Salt Lake City, Utah, USA.

Nature
|February 11, 2026
PubMed
まとめ
この要約は機械生成です。

エナチオセレクティブ反応のための新しい触媒の開発は,限られたデータのために困難です. この研究は,新しい反応の触媒性能を予測し,既存の反応を最適化するための新しい記述器戦略を導入しています.

さらに関連する動画

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

10.4K
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

1.2K

関連する実験動画

Last Updated: Feb 13, 2026

Development of Heterogeneous Enantioselective Catalysts using Chiral Metal-Organic Frameworks MOFs
08:25

Development of Heterogeneous Enantioselective Catalysts using Chiral Metal-Organic Frameworks MOFs

Published on: January 17, 2020

7.8K
Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

10.4K
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

1.2K

科学分野:

  • 有機化学 オーガニック・ケミストリー
  • コンピューティング・ケミストリー
  • カタリシス カタリシス カタリシス

背景:

  • 新しい反応におけるエナチオ選択性を最適化することは困難であり,特に触媒と基板の相互作用に関するデータが限られている.
  • 既存の統計モデルは,機械的に複雑な変換と稀少なデータセットで苦労しています.

研究 の 目的:

  • エナチオセレクティブ反応における触媒性能を予測するための新しい記述子生成戦略を開発する.
  • 異なるリガンドおよび基板タイプによる反応のモデリングを可能にし,データ不足に対処する.

主な方法:

  • 触媒/基質の同一性に基づいて,エナチオ決定段階の変化を考慮する生成された記述子.
  • エナチオセレクティブニッケル触媒C ((sp3)) カップリングに関するデータを収集した.
  • 提案された移行状態と中間値の特徴を用いた統計モデルを訓練した.

主要な成果:

  • 目に見えないリガンドと反応パートナーに適用できるモデルを開発しました.
  • サブストラット範囲内で,パフォーマンスが悪い例を成功裏に最適化しました.
  • 稀少なデータから新しい化学空間へ知識を定量的に転送するための戦略を示した.

結論:

  • 新しい記述子戦略は,複雑なエナチオセレクティブ反応を効果的にモデル化します.
  • このアプローチは,多様な化学空間における予測を可能にすることで,触媒と反応の開発を合理化します.
  • 限られたデータから,非対称な触媒の新たな応用への知識移転を容易にする.